این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Asia Pacific Journal of Medical Toxicology، جلد ۱۱، شماره ۲، صفحات ۷۷-۷۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Is Clonidine Useful for the Management of Tramadol-induced Withdrawal Syndrome?
چکیده انگلیسی مقاله Dear Editor-in-chiefTramadol is a synthetic opioid with non-opioid effects. It has a low affinity to opioid receptors and inhibits re-uptake of norepinephrine and serotonin in synapses [1- 5]. Tramadol is used to treat acute and chronic pains [6]. Although it is not an OTC (over the counter) medication, it has been accessible illicitly and abused by some drug-dependent people or sometimes ingested for deliberate self-harm or suicide [1- 3]. Previous studies showed widespread use, misuse and abuse of tramadol in Iran [1, 2]. In patients with or without a history of substance abuse, who were treated by tramadol, several side effects have been reported with high odds ratio (OR) including nausea, constipation, drowsiness, respiratory distress, rhabdomyolysis, acute renal failure, refractory seizures, dependence, and withdrawal syndrome [1, 2, 7, 8]. Clonidine, an alpha-2 adrenergic agonist, is a safe and effective non-opioid treatment for opiate withdrawal syndrome and exerts its effects by decreasing noradrenergic hyperactivity in the brain. Clonidine decreases symptoms and signs of withdrawal syndrome such as anxiety, irritability, restlessness, and anger in opium, opioid, or alcohol dependent patients [9, 10]. Clonidine detoxification allows these patients to become opiate-free and clonidine-free, however, maintenance treatment with naltrexone, group therapy, and other therapeutic approaches may be necessary to maintain the abstinence period [9]. Given the utility and effectiveness of clonidine in the treatment of withdrawal syndrome presentations, it seems that clonidine may also be effective for tramadol-induced withdrawal syndrome. Therefore, further studies in this line of research may be necessary.
کلیدواژه‌های انگلیسی مقاله Clonidine, Tramadol, Withdrawal
نویسندگان مقاله | Mohammad Majidi
Taleghani Hospital, Urmia, Iran.


| Solmaz Nekoueifard
General Practitioner, Health Center, Urmia, Iran


| Bita Dadpour
Bita Dadpour, MD. Assistant Professor, Toxicology Department, School of Medicine, Mashhad University of Medical Sciences.
نشانی اینترنتی https://apjmt.mums.ac.ir/article_20400.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Letter to Editor
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات